{"nct_id":"NCT02553499","title":"Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001)","status":"TERMINATED","status_verified_date":"2019-10","start_date":"2015-11-12","start_date_type":"ACTUAL","primary_completion_date":"2018-10-17","primary_completion_date_type":"ACTUAL","completion_date":"2018-10-17","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}